Beta Bionic, Inc. (BBNX)
Beta Bionic will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Company Description
Beta Bionic is a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.
Our product, the iLet Bionic Pancreas (iLet), is the first insulin delivery device cleared by the U.S. Food and Drug Administration to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake.
Beta Bionic, Inc.
| Country | United States |
| Founded | 2015 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 291 |
| CEO | Sean Saint |
Contact Details
Address: 11 Hughes Irvine, CA 92618 United States | |
| Phone | (949) 427-7785 |
| Website | betabionics.com |
Stock Details
| Ticker Symbol | BBNX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001674632 |
Key Executives
| Name | Position |
|---|---|
| Sean Saint | Chief Executive Officer and Director |
| Stephen Feider | Chief Financial Officer |
| Mike Mensinger | Chief Product Officer |
| Steven Russell, M.D., Ph.D. | Chief Medical Officer |
| Mark Hopman | Chief Commercial Officer |
| Edward Damiano, Ph.D. | Executive Chairman |
| Adam Lezack | Chairperson-elect |
| Sean Carney | Director |
| Dan Dearen | Director |
| Gilad Glick | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 6, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Dec 16, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Nov 25, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Oct 28, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Sep 13, 2024 | DRS | [Cover] Draft Registration Statement |
| Apr 25, 2024 | C-AR | Filing |
| Sep 15, 2023 | D | Notice of Exempt Offering of Securities |
| Apr 26, 2023 | C-AR | Filing |
| Sep 1, 2022 | C-AR/A | Filing |
| Apr 29, 2022 | C-AR | Filing |